BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 13, 2026
Breaking News: Ongoing coverage of the Ebola outbreakBreaking News: AI co-scientist performs biomedical research ‘at expert level’ in less timeBreaking News: Science fiction realized: BCI tech is here
Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
BioWorld Science, Conferences RSS Feed RSS

Benefit of phentermine/topiramate seen in type 2 diabetes patients in phase II trial

Oct. 13, 2009

RESOLVE results: improved visual acuity in diabetic macular edema with ranibizumab

Oct. 13, 2009

New atypical antipsychotic JNJ-37822681 enters phase II trial in schizophrenia

Oct. 13, 2009

Phase II data disclosed for ABT-869 in the treatment of RCC and HCC

Oct. 13, 2009

Promising preclinical data support TRK-380 as a novel candidate for OAB treatment

Oct. 9, 2009

Novel 5-HT2C receptor agonist PF-3246799 shows favorable activity in animal models

Oct. 9, 2009

BI-10773 exhibits promising preclinical antidiabetic activity in rodent models

Oct. 9, 2009

INCB-13739 added to metformin improves HbA1c and LDL-C in type 2 diabetes patients

Oct. 9, 2009

PK/PD data on the GLP-1 receptor agonist AVE-0010 presented at recent EASD meeting

Oct. 9, 2009

Vandetanib fails to meet primary endpoint in phase II trial in HCC patients

Oct. 9, 2009
Previous 1 2 … 1543 1544 1545 1546 1547 1548 1549 1550 1551 … 3094 3095 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing